Literature DB >> 1857338

Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors.

M Li1, R P Yasuda, S J Wall, A Wellstein, B B Wolfe.   

Abstract

The DNA fragment encoding the third intracellular loop of rat m2 muscarinic receptor was fused to the gene for staphylococcal Protein A. The resultant fusion protein, expressed in bacteria, was purified via IgG affinity chromatography and used as an antigen to raise a polyclonal antiserum. Chinese hamster ovary cells transfected with cDNA coding for a single muscarinic receptor subtype were used as tissue sources to screen antisera. The antiserum was shown to immunoprecipitate quantitatively (greater than 90%) m2 receptors but not to precipitate m1, m3, m4, or m5 receptors. Additionally, immunoprecipitation by m2 antiserum could be inhibited by protein containing the third intracellular loop of the m2 receptor. This selective m2 antiserum was then used to study the distribution and density of m2 receptors in rat brain and heart. In agreement with previous studies, m2 receptors were found to be abundant in heart and comprise at least 92% of the total muscarinic receptor density. Hindbrain, brain stem, and midbrain regions such as cerebellum (75%), pons/medulla (70%), and thalamus/hypothalamus (43%) are also enriched in m2 receptors. In contrast, forebrain regions contain markedly lower percentages of m2 receptors, with cortex expressing 20%, hippocampus 19%, striatum 12%, and olfactory tubercle 20% of the total receptor density. Although the density of m2 receptors expressed as a percentage of total varied considerably from brain region to brain region, the absolute density of these receptors appeared relatively uniform throughout the brain. This study demonstrates that a gene fusion system can be used for efficient antibody production. The use of similar fusion protein antisera directed against other subtypes of muscarinic receptors should prove useful in future studies on regulation, function, and structure of muscarinic receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1857338

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  14 in total

1.  Network activity in neurons of the motor and prefrontal areas of the cortex in trained cats in conditions of systemic administration of m-cholinoreceptor blockers.

Authors:  V N Khokhlova; G Kh Merzhanova; E E Dolbakyan
Journal:  Neurosci Behav Physiol       Date:  2002 Nov-Dec

2.  Opposing muscarinic and nicotinic modulation of hypoglossal motor output to genioglossus muscle in rats in vivo.

Authors:  Xia Liu; Sandeep Sood; Hattie Liu; Richard L Horner
Journal:  J Physiol       Date:  2005-04-07       Impact factor: 5.182

3.  Why does the agonist [(18)F]FP-TZTP bind preferentially to the M(2) muscarinic receptor?

Authors:  L Ravasi; D O Kiesewetter; K Shimoji; G Lucignani; W C Eckelman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12-07       Impact factor: 9.236

Review 4.  Autoradiographical and immunohistochemical analysis of receptor localization in the central nervous system.

Authors:  J G Chabot; S Kar; R Quirion
Journal:  Histochem J       Date:  1996-11

5.  Acetylcholine from the mesopontine tegmental nuclei differentially affects methamphetamine induced locomotor activity and neurotransmitter levels in the mesolimbic pathway.

Authors:  Lauren K Dobbs; Gregory P Mark
Journal:  Behav Brain Res       Date:  2011-09-17       Impact factor: 3.332

Review 6.  Muscarinic receptor regulation of the esophagus and lower esophageal sphincter.

Authors:  B Greenwood
Journal:  Dysphagia       Date:  1994       Impact factor: 3.438

7.  In vivo competition studies of Z-(-,-)-[125I]IQNP against 3-quinuclidinyl 2-(5-bromothienyl)-2-thienylglycolate (BrQNT) demonstrating in vivo m2 muscarinic subtype selectivity for BrQNT.

Authors:  V I Cohen; B R Zeeberg; S F Boulay; V K Sood; M R Rayeq; R A Danesh; D W McPherson; R C Reba
Journal:  J Mol Neurosci       Date:  1998-08       Impact factor: 3.444

8.  Decreased levels of muscarinic receptors in bladders from the alcohol preferring rat line.

Authors:  R J Smyth; K Kiianmaa; M R Ruggieri
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

9.  Comparison of the pharmacokinetics of different analogs of 11C-labeled TZTP for imaging muscarinic M2 receptors with PET.

Authors:  Alicia E Reid; Yu-Shin Ding; William C Eckelman; Jean Logan; David Alexoff; Colleen Shea; Youwen Xu; Joanna S Fowler
Journal:  Nucl Med Biol       Date:  2008-04       Impact factor: 2.408

10.  The detection of the non-M2 muscarinic receptor subtype in the rat heart atria and ventricles.

Authors:  Jaromir Myslivecek; Martin Klein; Martina Novakova; Jan Ricny
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-29       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.